UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 33

of 'Toxicity of molecularly targeted antiangiogenic agents: Non-cardiovascular effects'

33
TI
Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.
AU
Alexandrescu DT, McClure R, Farzanmehr H, Dasanu CA
SO
J Clin Oncol. 2008;26(24):4047.
 
AD
PMID